Orchid Pharma Ltd - 524372 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for quarter ending September, 202213-10-2022
13-10-2022
Orchid Pharma Ltd - 524372 - Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- MANISH DHANUKADesignation :- Managing Director / Whole Time Director13-10-2022
Orchid Pharma Ltd - 524372 - Closure of Trading Window
Intimation on Closure of Trading Window30-09-2022
Orchid Pharma Ltd - 524372 - Disclosure Under Regulation 30 Of SEBI LODR 2015.
Disclosure under Regulation 30 of SEBI LODR 2015.28-09-2022
Orchid Pharma Ltd - 524372 - Announcement Under Reg. 30 Of SEBI LODR 2015 - Intimation Of Investors Meeting
Announcement under Reg. 30 of SEBI LODR 2015 - Intimation of Investors Meeting26-09-2022
Orchid Pharma Ltd - 524372 - Disclosure Under Regulation 30 Of SEBI LODR 2015
Disclosure under Regulation 30 of SEBI LODR 201523-09-2022
Orchid Pharma Ltd - 524372 - Disclosure Under Regulation 30 Of SEBI LODR 2015.
Update - Disclosure under Regulation 30 of SEBI LODR 2015.23-09-2022
Orchid Pharma Ltd - 524372 - Disclosure Of Weblinks Of The Company Pursuant To The NSE Circulor - NSE/CML/2022/35 Dated 11Th July 2022 - Advisory Under Regulation 46 And 62 Of SEBI LODR
Disclosure of weblinks of the Company pursuant to the NSE Circulor - NSE/CML/2022/35 dated 11th July 2022 - Advisory under Regulation 46 and 62 of SEBI LODR15-09-2022
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Analysts/Investors Conference Call pertaining to the Financial Results for the Quarter ended June 30, 202217-08-2022
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Newspaper Publication dated August 11, 2022 - Unaudited Standalone & Consolidated Financial Results for the quarter ended June 30, 202211-08-2022